Endocrinology, Diabetes & Metabolism Case Reports (Jul 2021)

Oncogenic osteomalacia secondary to glomus tumor

  • Rishi Raj,
  • Samaneh Hasanzadeh,
  • Mitra Dashtizadeh,
  • Mohammadreza Kalantarhormozi,
  • Katayoun Vahdat,
  • Mohammad Hossein Dabbaghmanesh,
  • Iraj Nabipour,
  • Mohammdreza Ravanbod,
  • Majid Assadi,
  • Basir Hashemi,
  • Kamyar Asadipooya

DOI
https://doi.org/10.1530/EDM-20-0202
Journal volume & issue
Vol. 1, no. 1
pp. 1 – 4

Abstract

Read online

Oncogenic osteomalacia secondary to glomus tumor is extremely rare. Localization of causative tumors is critical as surgical resection can lead to a complete biochemical and clinical cure. We present a case of oncogenic osteomalacia treated with resection of glomus tumor. A 39-year-old woman with a history of chronic sinusitis presented with chronic body ache and muscle weakness. Biochemical evaluation revealed elevated alkaline phosphatase hypophosphatemia, increased urinary phosphate excretion, low calcitriol, and FGF23 was unsuppressed suggestive of oncogenic osteomalacia. Diagnostic studies showed increase uptake in multiple bones. Localization with MRI of paranasal sinuses revealed a sinonasal mass with concurrent uptake in the same area on the octreotide scan. Surgical resection of the sinonasal mass was consistent with the glomus tumor. The patient improved both clinically and biochemically postoperatively. Along with the case of oncogenic osteomalacia secondary to a glomus tumor, we have also discussed in detail the recent development in the diagnosis and management of oncogenic osteomalacia.